Cohen Fred E 4
4 · UroGen Pharma Ltd. · Filed Jul 28, 2023
Insider Transaction Report
Form 4
Cohen Fred E
Director
Transactions
- Award
Ordinary Shares
2023-07-26$9.54/sh+69,339$661,494→ 69,339 total(indirect: by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer)
Footnotes (1)
- [F1]Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer